Overview
Wolf-Hirschhorn syndrome (WHS), also known as 4p- syndrome or 4p deletion syndrome, is a rare genetic disorder caused by a partial deletion of the short arm of chromosome 4 (4p16.3). The critical region involves the WHSC1 (NSD2) and LETM1 genes. WHS is characterized by a distinctive facial appearance often described as a 'Greek warrior helmet' profile, featuring a broad forehead, prominent glabella, widely spaced eyes (hypertelorism), short philtrum, downturned mouth, and micrognathia. Affected individuals typically present with severe intrauterine and postnatal growth restriction, significant intellectual disability, and marked developmental delay. The syndrome affects multiple body systems. Seizures occur in approximately 90-100% of patients, often beginning in infancy, and may include various types of epilepsy that can be difficult to manage. Congenital heart defects are present in about 50% of cases, most commonly atrial and ventricular septal defects. Skeletal abnormalities, including scoliosis and delayed bone age, are common. Urogenital anomalies (particularly hypospadias in males and renal malformations), hearing loss, and immune deficiency with recurrent infections are also frequently observed. Feeding difficulties are nearly universal in infancy and may require gastrostomy tube placement. There is no cure for Wolf-Hirschhorn syndrome, and management is supportive and multidisciplinary. Treatment focuses on seizure control with antiepileptic medications, surgical correction of heart defects when indicated, nutritional support, and early intervention programs including physical therapy, occupational therapy, and speech therapy. Regular monitoring of growth, hearing, vision, and immune function is recommended. With improved medical care, survival into adulthood is increasingly common, though the degree of intellectual disability remains significant. Prognosis varies depending on the size of the chromosomal deletion and the severity of associated malformations.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Wolf-Hirschhorn syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Wolf-Hirschhorn syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Wolf-Hirschhorn syndrome.
Community
No community posts yet. Be the first to share your experience with Wolf-Hirschhorn syndrome.
Start the conversation →Latest news about Wolf-Hirschhorn syndrome
No recent news articles for Wolf-Hirschhorn syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Wolf-Hirschhorn syndrome
What is Wolf-Hirschhorn syndrome?
Wolf-Hirschhorn syndrome (WHS), also known as 4p- syndrome or 4p deletion syndrome, is a rare genetic disorder caused by a partial deletion of the short arm of chromosome 4 (4p16.3). The critical region involves the WHSC1 (NSD2) and LETM1 genes. WHS is characterized by a distinctive facial appearance often described as a 'Greek warrior helmet' profile, featuring a broad forehead, prominent glabella, widely spaced eyes (hypertelorism), short philtrum, downturned mouth, and micrognathia. Affected individuals typically present with severe intrauterine and postnatal growth restriction, significant
At what age does Wolf-Hirschhorn syndrome typically begin?
Typical onset of Wolf-Hirschhorn syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Wolf-Hirschhorn syndrome?
15 specialists and care centers treating Wolf-Hirschhorn syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.